- PanGenomic Health Inc.’s (NARA) subsidiary Mindleap Health Inc., is developing a cost-efficient all-in-one app to improve access to mental health resources
- New content will be added to the Mindleap library that educates and guides users
- The synchronization of the platform is planned to launch this quarter
- PanGenomic Health Inc. (NARA) is up 9.38 per cent, trading at $0.35 per share as of 2:46 p.m. EST
PanGenomic Health Inc.’s (NARA) subsidiary, Mindleap Health Inc., is developing an all-in-one app and telehealth platform for holistic mental wellness.
Mindleap’s goal is to improve the delivery of mental wellness from mood disorders to everyday resilience and capacity building. The all-in-one app and telehealth platform improves accessibility and saves time for both users and clinicians.
New content and new tools, such as internal family Systems, non-sleep deep rest, and vagal nerve stimulation, will be added to the Mindleap library. The platform is scheduled to launch this quarter.
The platform will allow users to self-guide their own mental health journey that encompasses new approaches to mental health management and give the option to speak to a practitioner via Mindleap’s telehealth functionality.
Maryam Marissen, CEO of PanGenomic Health, commented,
“Mental health management is a life-long endeavour, and we want to bring more leading-edge tools, programs, and practitioners… we want to help people with their immediate mental health concerns, we also want to help people build everyday resilience for the modern world.”
PanGenomic Health Inc. (NARA) is up 9.38 per cent, trading at $0.35 per share as of 2:46 p.m. EST.